clinical trial · NCT06881264
A Study Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd.·phase3·completed·n = 401
Adult Patients With Type 2 Diabetes Uncontrolled on Oral Antidiabetic DrugsHR17031 injectioninsulin glargine
brief summary
The aim of this trial is to confirm the efficacy of HR17031 in controlling glycaemia in Chinese subjects with type 2 diabetes mellitus inadequately controlled on oral antidiabetic agents
started
Apr 30, 2024
primary completion
Sep 19, 2025
completion
Sep 19, 2025
last updated
Jan 27, 2026
official title
A Randomized, Open-label, Parallel, Treat to Target Study Comparing the Efficacy and Safety of HR17031 With Insulin Glargine in Chines Subjects With Type 2 Diabetes Inadequately Controlled With Metformin in Combination With or Without Another Oral Antidiabetic Drug (OAD)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol